The cryptocurrency investment product market in the United States is becoming increasingly diverse. Recently, the Chicago Options Exchange (CBOE) submitted a listing application for a staking Injective (INJ) based exchange-traded fund (ETF) proposed by Canary Capital, joining the trend of expanding regulated staking ETF products.
This 19b-4 application is a follow-up procedure to the S-1 document submitted by Canary Capital to the U.S. Securities and Exchange Commission (SEC) last week. The application contains the structure and operation method of an INJ Token-based staking ETF, designed to allow investors to participate in verification services and receive staking rewards using an approved staking platform.
If this ETF is approved, it will become the third staking-based altcoin ETF. Previously, on June 30th, the SEC first approved staking Solana (SOL) and staking Ethereum (ETH) ETFs. This INJ ETF is similar in format, sharing the common characteristic of generating revenue streams from 'staking rewards'.
The fact that regulatory agencies are consecutively approving ETF products utilizing staking demonstrates the diversification trend of cryptocurrency financial products in the United States. Particularly, this trend is seen as a positive signal to the industry, reflecting a flexible approach to cryptocurrency investment during the Trump administration.
Industry experts predict that "as long as investors continue to demand safe access to cryptocurrency assets within regulations, various forms of ETFs are likely to continue emerging".
If the INJ-based ETF is approved, it will open a new path for both token issuers and investors to operate within a clear regulatory framework. While the specific approval schedule has not been disclosed, the movements of CBOE and SEC are showing a new horizon in the cryptocurrency ETF era.
Real-time news...Go to TokenPost Telegram
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
